Life Science & Biotechnology

The New Zealand Patent Office (“IPONZ”) is acutely aware of the High Court decision D’Arcy v Myriad Genetics Inc and of the Australian Patent Office’s proposed examination practice following...

Summary In a unanimous decision by seven Judges of Australia’s High Court (the highest appeal court), patent claims for isolated BRCA1 nucleic acids, indicative of a predisposition to breast or...

With the recent launch of The Official Australian Reference Guide to Agricultural Biotechnology and GM Crops, the Agricultural Biotechnology Council of Australia (the ABCA) has provided extensive new information...

It has been recently reported that the University of Queensland and an Indigenous community in north-west Queensland have signed an agreement that will potentially lead to a new industry...

There is extraordinary complexity and optimization underlying even comparatively ‘simple’ organisms. These powerful biological products and processes provide a great opportunity for humans; developing, building on and incorporating these...

In a decision published today, the Full Federal Court of Australia has dismissed an Appeal against the Federal Court decision of Justice Nicholas and thereby affirmed the patent eligibility...

Over 18 months ago the Australian Federal Court, in Cancer Voices Australia v Myriad Genetics Inc FCA 65 (15 February 2013) (“Myriad”), ruled that patent claims directed to...